Cargando…
Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer
BACKGROUND: Insights into the molecular pathogenesis of breast cancer might come from molecular analysis of tissue from early stages of the disease. METHODS: We conducted a case–control study nested in a cohort of women who had biopsy-confirmed benign breast disease (BBD) diagnosed between 1971 and...
Autores principales: | Rohan, Thomas E., Miller, Christopher A., Li, Tiandao, Wang, Yihong, Loudig, Olivier, Ginsberg, Mindy, Glass, Andrew, Mardis, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008400/ https://www.ncbi.nlm.nih.gov/pubmed/29872146 http://dx.doi.org/10.1038/s41416-018-0089-7 |
Ejemplares similares
-
MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer
por: Rohan, Thomas, et al.
Publicado: (2018) -
Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2021) -
A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer Risk
por: Kabat, Geoffrey C., et al.
Publicado: (2011) -
Risk factors for breast cancer development by tumor characteristics among women with benign breast disease
por: Figueroa, Jonine D., et al.
Publicado: (2021) -
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
por: Rohan, Thomas E, et al.
Publicado: (2021)